In what is being described as a breakthrough treatment option for patients with benign prostatic hyperplasia (BPH), researchers are studying the use of an interventional radiology treatment known as prostate artery embolization (PAE). Officials at the Society of Interventional Radiology (SIR) say PAE is a more effective minimally invasive treatment for BPH that is less invasive and has fewer complications than other options such as transurethral resection of the prostate. BPH, also referred to as an enlarged prostate, affects more than 50% of men 60 years and older in the US and more than 80% of men 80 years and older. (SeeAlso see "BPH: An Expanding Opportunity" - Medtech Insight, 1 September, 2008..)
News and data from the study were released at SIR’s 40th Annual Scientific Meeting, held from February 28 to March...